Shares of RxSight Inc. (RXST) are up over 20% at $49 in premarket trading, following strong second-quarter results and upbeat outlook for the year.
RxSight is a commercial-stage medical technology company providing light adjustable intraocular lens for post-cataract surgery patients. The company markets FDA-approved proprietary RxSight Light Adjustable Lens system, which consists of Light Adjustable Lens (LAL), Light Delivery Device (LDD) and accessories.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.